
Cheek implants are a surgical option for changing cheek contour with a solid implant. They should be considered in relation to an assessed facial concern, the particular device proposed and the consequences of having that device over time. Projection, symmetry and surface appearance are different goals. A photograph that makes the cheeks look wider does not establish that an implant is appropriate, and a preference for more projection does not identify the correct device or operation.
ASPS distinguishes solid cheek implants from augmentation using a person’s own transferred fat and from nonsurgical injectable fillers. Those are different treatment categories, not interchangeable versions of one service. The useful first decision is what change you want and what its proposed means would involve. ASPS cheek augmentation guidance
This guide explains how to separate contour goals, compare proposed treatment scope, preserve device information and interpret studies whose counts may refer to people, implants or combined operations. It does not select an implant or provide instructions for surgery.
Define the contour concern in three views
A face is three-dimensional, while most online comparisons are flat images. Describe your concern from the front, a three-quarter view and the side, using your own face as the reference. Ask which view communicates the problem most accurately and whether the proposed change might look different from another angle. More apparent width in one image is not a complete description of cheek projection.
Use consistent lighting and a relaxed expression when presenting photographs for discussion. A smile, a tilted head or light falling from a different direction can change the visible contour. The purpose is to communicate a preference, not to calculate an implant size from pixels. Request an explanation of what the clinician assesses in person that the images cannot establish.
If asymmetry is your main concern, identify what you notice without assuming that both sides need the same treatment. Ask how the current difference will be described and what degree of residual difference should be expected or discussed. A planning conversation should not promise mathematical symmetry simply because an implant has a manufactured shape.
Keep surface concerns separate. If the issue you notice is texture, discoloration or a line on the skin, ask whether a contour operation addresses it at all. If you are concerned about sagging, request the clinician’s explanation of the relationship between that concern and the proposed augmentation. Do not let the broad word rejuvenation combine every visible feature into one promised result.
| Goal description | Clarification to request | Weak evidence for the goal |
|---|---|---|
| Greater projection | Which region and view communicate the intended change? | A single front-view width comparison |
| Improved symmetry | What is the baseline difference and realistic remaining uncertainty? | Identical device labels alone |
| Different surface appearance | Is the issue contour, texture or another concern? | Assuming added volume treats every skin feature |
| Broader facial preference | Which change is actually proposed? | An ideal-proportion grid from someone else’s face |
Compare treatment categories before comparing devices
The distinction between an implant, transferred fat and a filler matters because you are choosing a type of treatment as well as an appearance goal. Ask the clinician to explain why the proposed category fits the assessed concern and what alternatives would require. A preference for a particular look does not by itself establish that one category is safest or best.
For an implant proposal, request the exact material, manufacturer and device identity in the written plan. For an alternative proposal, ask for equally specific information about what is being used and the course of care. Do not compare an identified surgical device with a vague phrase such as natural enhancement. Each option needs its own explanation of benefits, uncertainty and follow-up.
Avoid assuming that a less invasive label resolves every safety question. Nor should an implant be presented as automatically superior because it is intended to remain in place. Ask what further treatment could be needed and how a future concern would be assessed. The word permanent should not substitute for a discussion of possible revision or changes in preference.
If you have had previous filler, facial surgery, injury or reconstructive treatment, bring available records. The assessment should start with the actual prior course rather than the name you remember from an advertisement. Keep past material, treatment dates and the region treated separate from the new proposed device. An online guide cannot determine how previous treatment affects your plan.
Build a device record you can use later
Ask what implant information you will receive after surgery and retain it with the operative record. The useful record identifies the device and the side or region where it was placed. If there are different devices on the two sides, preserve that distinction. A receipt saying cheek augmentation is not necessarily a complete device record.
Request an explanation of the device’s applicable intended use and regulatory documentation rather than inferring those details from its material. A historical silicone-implant article does not establish the authorization, performance or compatibility of a different contemporary product. Likewise, an implant pictured on a website does not identify what would actually be used in your operation.
Ask how future clinicians can obtain the relevant records if the original practice is unavailable. Keep copies that you can access independently rather than relying on a marketing portal. This is practical continuity planning, not an expectation that a complication will occur. It also supports an accurate discussion if you later wish to change the contour or remove a device.
Do not assume that a photograph, a brand name or the word custom proves a better outcome. Ask what the customization actually changes and what evidence supports the proposed benefit. A model or simulation should be identified as planning material. It should not be described as an observed result or a guarantee that your face will match its displayed surface.
| Record element | Reason to preserve it | Question to ask |
|---|---|---|
| Device identity and material | Distinguishes the actual product from a general procedure | What exact documentation will I receive? |
| Side and region | Maintains the relationship between device and treatment area | Are both sides receiving the same product? |
| Complete operation | Keeps combined procedures visible | What else is being performed? |
| Follow-up and contact plan | Supports later assessment and continuity | How can records and advice be obtained later? |
Read implant studies with the unit intact
Device dimensions are not an appearance measurement
If the consultation includes an implant drawing, ask what its dimensions describe and how that relates to the proposed visible contour. A dimension on the device is not itself a measured change in your face. The discussion should connect the product to the assessed region without asking you to select an implant from a catalogue. Avoid adding dimensions from a model to measurements on a selfie as though the relationship were a simple arithmetic rule.
Ask how a simulation is intended to be used and what uncertainty it leaves. A front-view image may emphasize width while a side view emphasizes projection; neither settles your preference for all expressions and angles. Keep any simulation with its date and the proposed treatment scope, so that a later comparison does not confuse different plans. An illustration is useful when it explains a choice clearly, but it is not observed surgical evidence.
If treatment is being discussed after trauma or previous reconstruction, clarify whether the goal is correction of a particular acquired contour difference or a broader cosmetic preference. Those purposes may lead to different comparisons in the literature. Do not assume that a study containing reconstructive patients automatically describes an elective bilateral augmentation. The source should identify the population, and the clinical discussion should explain its relevance to your own proposed course.
A July 1995 retrospective silicone malar-implant report describes 64 people, 126 implants and 11 people receiving unilateral placement. It also reports that 79% had other surgical procedures at the same time. The abstract does not reconcile the relationship between all those units. Its device-size counts add to the reported implant total, but that does not establish a simple one-device-per-side patient table. Original silicone malar-implant report
People, implants and operations are different units
Do not divide an event described in people by a count of implants without knowing the intended denominator. Nor should the remaining difference be invented as repeat operations or missing participants. An unresolved abstract detail is a limit to record, not an invitation to complete the dataset with an assumption. The original report’s mixed cosmetic and reconstructive context also matters when applying it to an elective contour preference.
A separate December 1995 report describes 22 people receiving cheek augmentation and advancement with lower eyelid blepharoplasty. Mean follow-up was 44 months, ranging from 12 to 78 months. Reported events included two hematomas, two transient ectropions, one palpable implant edge and one requested implant removal. Those observations belong to the combined course; the categories are not an additive total or an isolated implant risk estimate. Original combined cheek and eyelid series
The proposed supporting chart displays those separate counts with the 22-person denominator and follow-up alongside them. It does not create a success remainder, compare the historical studies as though they were competing trials or turn the counts into today’s personal probability. This is useful evidence literacy: a chart can make the actual observation clearer while preserving the questions it cannot answer.
| Study feature | July 1995 series | December 1995 series |
|---|---|---|
| Reported units | 64 people; 126 implants; 11 unilateral placements | 22 people |
| Scope | Cosmetic and reconstructive; mostly combined procedures | Combined cheek and lower-eyelid course |
| Key limitation | Abstract unit relationship unresolved | Cannot isolate the implant contribution |
| Useful interpretation | Keep people and devices distinct | Keep separate events and follow-up visible |
| Unsupported inference | Device count as personal-risk denominator | Modern isolated-implant risk or additive total |
Safety needs an individualized explanation
ASPS lists infection, implant shifting, contour irregularities, sensory changes, persistent pain and possible revision among facial-implant risks. Its guidance gives categories to discuss, not a cheek-specific event rate. Ask how the team relates those risks to the particular operation and your history. The fact that a study reports few events does not remove the need for that discussion. ASPS facial-implant risk guidance
Separate a cosmetic concern from a symptom that needs assessment. If something feels different after a procedure, describe the location, timing and associated symptoms to the treating team rather than diagnosing a device problem from an image. Obtain instructions about when to contact the team and where to seek urgent care. Do not wait for an online comment if you have a concerning or rapidly changing problem.
Ask who manages a possible implant concern and what evaluation may involve. This should be clear before surgery, especially if you would be traveling. A later need for assessment can create practical and financial responsibilities even when the original procedure was elective. The plan should explain access to care rather than simply promising that you can send a photograph.
Do not attempt to push, reposition or massage an implant based on another person’s experience. Follow the treating team’s instructions for your actual course. This guide does not prescribe wound care, medication or a maneuver to test whether an implant has shifted. If you are unsure what an instruction means, ask the team to explain it rather than improvising.
Combined procedures change the meaning of an outcome
If cheek implants are proposed together with eyelid surgery, a facelift or another facial procedure, ask for a component-level plan. Identify which concern each component addresses and which changes are optional. A combined before-and-after photograph cannot tell you how much of the visible difference came from each component unless that distinction has been established separately.
The existing blepharoplasty guide and facelift guide can help you understand the separate decisions. Use them as context for questions, not as permission to combine operations. The clinical assessment and complete consent discussion remain specific to the proposed treatment.
Ask whether a quoted study used the same combination, indication and follow-up. If it did not, request an explanation of why it is relevant and where the comparison stops. A result after a combined course is still informative, but it should remain attributed to that course. Giving all credit to the implant can make an appearance claim stronger than the evidence supports.
If you prefer only one component, say so explicitly and ask how that changes the proposed goal. You should understand whether the team believes the isolated procedure addresses your concern or whether it would produce a different result. The answer may be uncertainty, a different recommendation or a decision not to proceed. A bundle should not hide that discussion.

Prepare for follow-up with endpoints rather than a fixed calendar
Ask for instructions suited to the actual implant and any additional procedures. There is no universal recovery timetable supplied here. Request guidance for work, activity, follow-up and situations that require contact. If your job involves travel, public appearances or physical activity, describe those demands directly rather than asking only when swelling will disappear.
Keep comfort, appearance and the clinician’s assessment on separate lines in follow-up notes. Record the date and context of a concern so that it is not reduced to a comparison between two photographs. A visible difference and a symptom can be related or separate; the treating clinician should interpret them. The record is a communication aid, not a tool for deciding on your own that revision is necessary.
Ask when the team intends to discuss the appearance result and which decisions depend on examination. A single early image should not become a final verdict on the operation. Conversely, a pleasing image should not override an unresolved symptom. The recovery planning guide helps organize practical support without replacing individualized instructions.
Compare the complete cost and future responsibilities
No verified cheek-implant total-price dataset is provided here. Obtain a written estimate naming the device, surgeon fee, anesthesia, facility, additional procedures and follow-up. Ask what is included if an implant-related concern needs evaluation. The price of a general facial-augmentation package cannot be assumed to represent an isolated cheek-implant course.
Compare estimates only after their scope is aligned. One may include a device-specific planning process or several facial procedures while another includes a narrower operation. Ask about those differences without assuming the larger or more expensive proposal is better. The cost planning guide explains why a surgeon fee is not the complete financial picture.
Discuss the handling of later revision, removal or changed preferences before making the decision. Clarify which costs are addressed by written policy and which would require a new estimate. A statement that a concern can be treated does not establish that future care is free or covered by insurance. Keep the medical explanation and financial terms separate so that neither is inferred from the other.
Decide from your own goal, not a manufactured ideal
Summarize the desired contour change, assessed concern, exact proposed device, combined procedures and remaining uncertainties in plain language. If you cannot explain why an implant is being proposed rather than another category, request clarification before consenting. A readable plan is more useful than an ideal-face diagram that gives every person the same target.
It is reasonable to pause an elective decision when the goal remains unclear or the evidence is being overstated. You can also decide that a possible contour change is not worth the surgical and device-related responsibilities. There is no obligation to choose a procedure simply because a simulation looks attractive or a historical report sounds favorable.
Use the procedure library for further context. A thoughtful cheek-implant decision keeps projection, symmetry, surface concerns and future device care distinct, and preserves the actual units and limitations of the evidence used to support it.
Sources and review scope
Plastic Surgery Editorial Team. Source records checked through October 12, 2026. Review scope: source and editorial checks for general education. No individual clinical assessment is represented.
- ASPS cheek augmentation scope. plasticsurgery.org. Publication/update date not stated. Checked 2026-10-12.
- ASPS facial implant risks. plasticsurgery.org. Publication/update date not stated. Checked 2026-10-12.
- Original silicone malar implant series. pubmed.ncbi.nlm.nih.gov. Source date: 1995-07. Checked 2026-10-12.
- Original combined malar augmentation, cheek advancement and blepharoplasty series. pubmed.ncbi.nlm.nih.gov. Source date: 1995-12. Checked 2026-10-12.